Physician profile

Harvey Katz

Foot & Ankle Surgery · Sunrise, FL

NPI 1477581304

$309.61

in general payments reported to CMS, 2019-2025

7 companies · $29.68 in 2025

The $29.68 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).

See the full distribution for Foot & Ankle Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$197.26

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $101.94 2023
Ortho Dermatologics, A Division of Bausch Health US, LLC $96.63 2020
Smith+Nephew, INC. $29.68 2025 Collagenase Santyl
Paratek Pharmaceuticals, INC. $28.41 2022-2023 Nuzyra
Medtronic, INC. $19.31 2024 Closurefast
Organogenesis INC. $17.64 2023 Puraply
Abbott Laboratories $16.00 2023 Proclaim

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Harvey Katz

$309.61

in general payments reported 2019-2025

Years
2020-2025
Top company
Abbvie INC.
Context
The $29.68 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).

https://glasscript.com/doctor/1060110/harvey-katz

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.